Skip to main content
Article
The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
Clinical & Population Health Research
  • Shaun G. Goodman, University of Toronto
  • Wei Huang, University of Massachusetts Medical School Worcester
  • Andrew T. Yan, University of Toronto
  • Andrzej Budaj, Grochowski Hospital
  • Brian M. Kennelly, Hoag Memorial Hospital Presbyterian
  • Joel M. Gore, University of Massachusetts Medical School
  • Keith A. A. Fox, University of Edinburgh
  • Robert J. Goldberg, University of Massachusetts Medical School
  • Frederick A. Anderson, University of Massachusetts Medical School
Student Author(s)
Wei Huang
UMMS Affiliation
Center for Outcomes Research; Department of Medicine, Division of Cardiovascular Medicine
Date
8-22-2009
Document Type
Article
Medical Subject Headings
Acute Coronary Syndrome; Quality of Health Care; Evidence-Based Medicine
Abstract
BACKGROUND: The Global Registry of Acute Coronary Events (GRACE)-a prospective, multinational study of patients hospitalized with acute coronary syndromes (ACSs)-was designed to improve the quality of care for patients with an ACS. Expanded GRACE aims to test the feasibility of a simplified data collection tool and provision of quarterly feedback to index individual hospital management practices to an international reference cohort. METHODS: We describe the objectives; study design; study and data management; and the characteristics, management, and hospital outcomes of patients > or =18 years old enrolled with a presumptive diagnosis of ACS. RESULTS: From 2001 to 2007, 31,982 patients were enrolled at 184 hospitals in 25 countries; 30% were diagnosed with ST-segment elevation myocardial infarction, 31% with non-ST-segment myocardial infarction, 26% with unstable angina, and 12% with another cardiac/noncardiac final diagnosis. The median age was 65 (interquartile range 55-75) years; 24% were >75 years old, and 33% were women. In general, increases were observed over time across the spectrum of ACS (1) in the use in the first 24 hours and at discharge of aspirin, clopidogrel, beta-blockers, and angiotensin-converting enzyme inhibitors/receptor blockers; (2) in the use at discharge of statins; (3) in the early use of glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparin; and (4) in the use of cardiac catheterization and percutaneous coronary intervention. An increase in the use of primary percutaneous coronary intervention and a similar decrease in the use of fibrinolysis in ST-segment elevation myocardial infarction were also seen. CONCLUSIONS: Over the course of 7 years, general increases in the use of evidence-based therapies for ACS patients were observed in the expanded GRACE.
Rights and Permissions
Citation: Am Heart J. 2009 Aug;158(2):193-201.e1-5. Link to article on publisher's site
Related Resources
Link to Article in PubMed
PubMed ID
19619694
Citation Information
Shaun G. Goodman, Wei Huang, Andrew T. Yan, Andrzej Budaj, et al.. "The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes" Vol. 158 Iss. 2 (2009) ISSN: 1097-6744 (Electronic)
Available at: http://works.bepress.com/robert_goldberg/133/